Published in Obesity and Diabetes Week, January 30th, 2006
According to recent research from People's Republic of China, "Orlistat promotes weight loss in overweight and obese patients with type 2 diabetes receiving hypoglycemic treatment, but has not been investigated in patients with newly diagnosed and previously untreated type 2 diabetes. We evaluated the efficacy of 24 weeks' treatment with orlistat, combined with a mildly reduced-calorie diet, on weight loss and glycemic control in overweight and obese patients with newly diagnosed and previously untreated type 2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.